ClinicalTrials.gg
RecruitingNCT07272252NARRCAREUpdated Sep 16, 2026

Narrative Nursing for Cesarean Mothers' Anxiety and Breastfeeding Confidence

An interventional study of 4-step narrative nursing program in Postpartum Anxiety, Postpartum Depression (PPD) and Breastfeeding Self-Efficacy, sponsored by Xi Huang. Recruiting at 1 site in China. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Xi Huang · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

This study tests whether a nurse-led "4-step narrative nursing" program can reduce anxiety and improve breastfeeding confidence in mothers who are having a planned or non-emergency cesarean section.

What is the problem? About 30-40% of Chinese cesarean mothers feel high anxiety after surgery, and 1 in 5 is at risk for postpartum depression. Low confidence in breastfeeding is also common.

What will we do?

We will randomly assign 160 mothers (1:1) to either:

Usual care - standard education and ward care, or

Usual care plus narrative nursing - four short (10-20 min) conversations with a trained nurse:

Before surgery - help the mother talk about her fears. 24-48 h after surgery - encourage her to "name" pain or worries and separate them from herself.

Before discharge - guide her to find positive moments and build a "strong-mom" story.

Two weeks later by phone - strengthen the new story and review feeding success. What will we measure? Main result: anxiety score at 48 h (STAI scale). Other results: depression risk, breastfeeding confidence, pain, and feeding rates up to 3 months.

Possible benefits:

Lower anxiety, better mood, higher breastfeeding rates. No drugs or extra procedures are involved, only talking.

Risks:

Minimal; some mothers may feel emotional during conversations, but nurses can pause or refer to counselling if needed.

02

Conditions studied

  • Postpartum Anxiety
  • Postpartum Depression (PPD)
  • Breastfeeding Self-Efficacy
  • Cesarean Section Wound

Keywords

  • narrative nursing
  • storytelling intervention
  • cesarean section
  • postpartum anxiety
  • breastfeeding confidence
  • mixed-methods
  • randomized controlled trial
  • China
03

In context

Depression, Postpartum

569 studies on the registry are indexed under Depression, Postpartum; 134 are open to participants now.

This study's planned enrollment of 160 is above the median of 104 across 454 interventional studies indexed under Depression, Postpartum.

Browse Depression, Postpartum studies →

Lead sponsor

This is the only study on the registry with Xi Huang as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Women aged 18-50 years
  2. Scheduled for elective or non-emergency cesarean section at ≥37 weeks
  3. Able to communicate in Mandarin and provide written
  4. Expected hospital stay ≥24 h
  5. Singleton pregnancy with stable maternal and neonatal condition allowing routine mother-baby contact

Exclusion criteria

Exclusion Criteria:

  1. Severe psychiatric disorders (schizophrenia, bipolar disorder, active suicidal ideation)
  2. Maternal or neonatal need for ICU/NICU admission
  3. Emergency cesarean section preventing baseline assessment
  4. Communication or cognitive impairment precluding interview
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
160 participants (estimated)

Study arms

  • No intervention
    Routine perinatal care

    Participants receive standard ward education, nursing care, discharge instructions, and routine telephone follow-up without any additional narrative sessions.

  • Experimental
    4-step narrative nursing

    Participants receive usual care plus four nurse-led narrative sessions (pre-op externalization, post-op deconstruction, pre-discharge reconstruction, and 2-week meaning-reconstruction phone call) aimed at reducing anxiety and enhancing breastfeeding confidence.

    Behavioral: 4-step narrative nursing program

Interventions

  • Behavioral4-step narrative nursing program

    Four nurse-led storytelling sessions (pre-operative externalization, post-operative deconstruction, pre-discharge reconstruction, and 2-week meaning-reconstruction phone call) aimed at reducing anxiety and increasing breastfeeding self-efficacy.

06

What researchers measure

Primary outcomes

  1. Postpartum anxiety at 48 hours

    Mean score on the State-Trait Anxiety Inventory (STAI-State, 20 items) assessed 48 hours after cesarean delivery. Lower scores indicate less anxiety.

    Time frame: 48 hours post-surgery

Secondary outcomes

  1. Postpartum depression risk

    Proportion of women with Edinburgh Postnatal Depression Scale (EPDS) ≥ 10 at 48 hours, 2 weeks and 3 months.

    Time frame: 48 hours, 2 weeks, 3 months postpartum

  2. Breastfeeding self-efficacy

    Mean score on the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF, 14 items) at 48 hours, 2 weeks and 3 months. Higher scores indicate greater confidence.

    Time frame: 48 hours, 2 weeks, 3 months postpartum

  3. Pain intensity

    Mean Numerical Rating Scale (NRS, 0-10) for self-reported pain at 48 hours and 2 weeks.

    Time frame: 48 hours and 2 weeks postpartum

  4. Breastfeeding continuation rate

    Percentage of women who report any breastfeeding at 3 months.

    Time frame: 3 months postpartum

07

Study locations

1 of 1 sites recruiting
  • Yilong County Maternal and Child Health Hospital
    Nanchong, Sichuan 637600, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Yes, we plan to share individual participant data (IPD). The de-identified IPD underlying published results will be made available to qualified researchers beginning 9 months after article publication and ending 36 months post-publication. Data access will be granted after approval of a methodologically sound proposal and execution of a data-sharing agreement. Interested parties should contact the corresponding author.

Supporting information: Study protocol, Informed consent form

Time frame: IPD and supporting information will be made available beginning 9 months after the primary results paper has been accepted for publication and ending 36 months after that date. An extension may be granted if a justifiable request is received before the closing date.

Access criteria: Access is limited to qualified researchers with IRB/REC-approved, methodologically sound proposals relevant to the approved indication. Only de-identified participant data and the data dictionary will be provided. Requests should be e-mailed to 【corresponding-author@univ.edu】 with a 1-page protocol and statistical analysis plan. A data-sharing agreement outlining terms of use, confidentiality, and no attempt to re-identify participants must be signed before access is granted. Data will be shared through a password-protected secure cloud link; download is logged and audited.

Data sharing details ↗ · med.xmu.edu.cn

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07272252
Lead sponsor
Xi Huang
Collaborators
Xiamen University, Yilong People's Hospital
Responsible party
Xi Huang (Master's student, Xiamen University) — Sponsor-investigator
First posted
Dec 9, 2025
Start date
Oct 1, 2025
Primary completion
Sep 25, 2026 (estimated)
Completion
Sep 25, 2026 (estimated)
Last update
Sep 16, 2026

Study contacts

X i Huang
Contact
24520241154909@stu.xmu.edu.cn
+86-156-8090-6987
Yinchun Tan
Contact
2027687568@qq.com
+86-152-8329-4749

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion